参考文献/References:
[1] Vogrig A, Gigli GL, Bnà C, et al. Stroke in patients with COVID-19: clinical and neuroimagingcharacteristics[J]. Neurosci Lett, 2021, 743: 135564.
[2] Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19[J]. Lancet Neurol, 2020, 19(9): 767-783.
[3] Galán J. Stroke as a complication and prognostic factor of COVID-19-ScienceDirect[J]. Neurología(English Edition), 2020, 35(5): 318-322.
[4] Siegler JE, Cardona P, Arenillas JF, et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry[J]. Int J Stroke, 2021, 16(4): 437-447.
[5] Zubair AS, Mcalpine LS, Tova G, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019a review[J]. JAMA Neurol, 2020, 77(8): 1018-1027.
[6] Ghannam M, Alshaer Q, Al-Chalabi M, et al. Neurological involvement of coronavirus disease 2019: a systematic review[J]. J Neurol, 2020, 267(11): 3135-3153.
[7] Lazcano U, Cuadrado-Godia E, Grau M, et al. Increased COVID-19 mortality in People with previous cerebrovascular disease: a Population-Based cohort study[J]. Stroke, 2022, 53(4): 1276-1284.
[8] Naval-Baudin P, Rodriguez CI, Rubio-Maicas C, et al. COVID-19 and ischemic stroke: clinical and neuroimaging findings[J]. J Neuroimaging, 2021, 31(1): 62-66.
[9] Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system[J]. Cell, 2020, 183(1): 16-27.e1.
[10] Avula A, Nalleballe K, Narula N, et al. COVID-19 presenting as stroke[J]. Brain Behav Immun, 2020, 87(4): 115-119.
[11] Hernández-Fernández F, Sandoval VH, Barbella-Aponte RA, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description[J]. Brain, 2020, 143(10): 3089-3103.
[12] Lee MH, Perl DP, Nair G, et al. Microvascular injury in the brains of patients with covid-19[J]. N Engl J Med, 2021, 384(5): 481-483.
[13] Qiu F, Wu Y, Zhang A, et al. Changes of coagulation function and risk of stroke in patients with COVID-19[J]. Brain Behav, 2021, 11(6): e02185.
[14] Dekosky ST, Kochanek PM, Valadka AB, et al. Blood biomarkers for detection of brain injury in COVID-19 patients[J]. J Neurotrauma, 2021, 38(1): 1-43.
[15] Janardhan V, Janardhan Vauid- Orcid: 0000-0003-3137-9626ad-Stroke & Interventional Neurology MC, Kalousek V. COVID-19 as a blood clotting disorder masquerading as a respiratory illness: a cerebrovascular perspective and therapeutic implications for stroke thrombectomy[J]. J Neuroimaging, 2020, 30(5): 555-561.
[16] Finsterer J. Consider alternative causes before allocating acute ischaemic stroke to COVID-19 [J]. J Neurol Neurosurg Psychiatry, 2022, Doi: 10.1136/jnnp-2022-329029.
[17] Venketasubramanian N, Anderson C, Ay H, et al. Stroke care during the COVID-19 pandemic: international expert panel review[J]. Cerebrovasc Dis, 2021, 50(3): 245-261.
[18] Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with covid-19[J]. N Engl J Med, 2020, 382(17): e38.
[19] Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19[J]. J Neurol Neurosurg Psychiatry, 2020, 91(8): 889-891.
[20] Piazza G, Campia U, Hurwitz S, et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19[J]. J Am Coll Cardiol, 2020, 76(18): 2060-2072.
[21] 陈壮壮,李国忠.COVID-19相关脑梗死的临床特征及其机制的研究进展[J].卒中与神经疾病,2021,28(04):447-450.
[22] Zakeri A, Jadhav AP, Sullenger B, et al. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist[J]. J Neurointerv Surg, 2021, 13(3): 202-206.
[23] Ao, Liew SC, Mohd NM, et al. SARS-CoV-2 infection of the nervous system: a review of the literature on neurological involvement in novel coronavirus disease-(COVID-19)[J]. Bosn J Basic Med Sci, 2020, 20(3): 283-292.
[24] Ahmad I, Rathore F. Neurological manifestations and complications of COVID-19: a literature review[J]. J Clin Neurosci, 2020, 77(5): 8-12.
[25] Fan H, Tang X, Song Y, et al. Influence of COVID-19 on cerebrovascular disease and its possible mechanism[J]. Neuropsychiatr Dis Treat, 2020, 16:1359-1367.
[26] South K, Mcculloch L, Mccoll BW, et al. Preceding infection and risk of stroke: an old concept revived by the COVID-19 pandemic[J]. Int J Stroke, 2020, 15(7): 722-732.
[27] Sadeghmousavi S, Rezaei N. COVID-19 infection and stroke risk[J]. Rev Neurosci, 2021, 32(3): 341-349.
[28] Berger JR. COVID-19 and the nervous system[J]. J Neurovirol, 2020, 26(2): 143-148.
[29] Divani AA, Andalib S, Biller J, et al. Central nervous system manifestations associated with COVID-19[J]. Curr Neurol Neurosci Rep, 2020, 20(12): 60.
[30] Sidig A, Abbasher K, Abbasher H, et al.COVID-19 and ischemic stroke[Z],2020.
[31] Nannoni S, De Groot R, Bell S, et al. Stroke in COVID-19: a systematic review and meta-analysis[J]. Int J Stroke, 2021, 16(2): 137-149.
[32] Divani AA, Andalib S, Di Napoli M, et al. Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights[J]. J Stroke Cerebrovasc Dis, 2020, 29(8): 104941.
[33] Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related stroke[J]. Transl Stroke Res, 2020, 11(3): 322-325.
[34] Tsivgoulis G, Palaiodimou L, Zand R, et al. COVID-19 and cerebrovascular diseases: a comprehensive overview[J]. Ther Adv Neurol Disord, 2020, 13: Doi: 10.1177/1756286420978004.
[35] Najjar S, Najjar A, Chong DJ, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports[J]. J Neuroinflammation, 2020, 17(1): 231.
[36] Frisullo G, Scala I, Bellavia S, et al. COVID-19 and stroke: from the cases to the causes[J]. Rev Neurosci, 2021, 32(6): 659-669.
[37] Stein LK, Mayman N, Dhamoon MS, et al. The emerging association between COVID-19 and acute stroke[J]. Trends Neurosci, 2021, 44(7): 527-537.
[38] Spence JD, De Freitas GR, Pettigrew LC, et al. Mechanisms of stroke in COVID-19[J]. Cerebrovasc Dis, 2020, 49(4): 451-458.
[39] Styczen H, Maus V, Goertz L, et al. Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients: multicenter experience in 111 cases[J]. J Neurointerv Surg, 2022, 14(9): 858-862.
[40] Zhai P, Ding Y, Li Y. The impact of COVID-19 on ischemic stroke[J]. Diagn Pathol, 2020, 15(1): 78.
[41] Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study[J]. Stroke Vasc Neurol, 2020, 5(3): 279-284.
[42] Siepmann T, Barlinn K. Der Zusammenhang zwischen COVID-19 und schlaganfall: pathophysiologie und klinische bedeutung(Association of COVID-19 and stroke: pathophysiology and clinical relevance)[J]. Fortschr Neurol Psychiatr, 2021, 89(6): 289-295.
[43] Akhtar N, Abid F, Singh R, et al. Characteristics and comparisons of acute stroke in “recovered” to “active COVID-19” and “pre-pandemic” in Qatar database[J]. Journal of Thrombosis and Thrombolysis, 2022, 53(4): 824-828.
[44] 新型冠状病毒肺炎诊疗方案(试行第九版)[J].中国医药,2022,17(4):481-487.
[45] 杨梦,周鹏.中医“治未病”思想探讨针灸对新型冠状病毒肺炎(COVID-19)的防治作用[J].针灸临床杂志,2022,38(01):82-85.